Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Annals of Surgery|May 5, 2025
Abnormal Milan Score and Compromised Esophageal Mucosal Integrity Stratify Gastroesophageal Reflux Disease SeverityMarco Sozzi, Stefano Siboni, Pierfrancesco Visaggi, et al.
United European Gastroenterology Journal|March 27, 2024
The Milan score: A novel manometric tool for a more efficient diagnosis of gastro-esophageal reflux diseaseStefano Siboni, Marco Sozzi, Ivan Kristo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2025
Effectiveness and Safety of Orodispersible Budesonide for Eosinophilic Esophagitis: A Multicenter Real-World StudyDaria Maniero, Matteo Ghisa, Alessandro Bruschi, et al.
Neurogastroenterology and Motility|July 16, 2026
Inter-Observer Variability of Gerd-Related Metrics on High-Resolution Manometry and Calculation of the Milan ScoreMarco Sozzi, Stefano Siboni, Andres R Latorre-Rodriguez, et al.
Inflammatory Bowel Diseases|May 23, 2018
Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European StudyUri Kopylov, Bram Verstockt, Luc Biedermann, et al.
The American Journal of Gastroenterology|June 23, 2026
Dupilumab for Eosinophilic Esophagitis in Adolescents and Adults: Real-World Outcomes Across Different Dosing Regimens from the EoE CONNECT RegistryEmilio J Laserna-Mendieta, Victoria Úbeda-Vargas, Edurne Amorena, et al.
Advances in Therapy|June 30, 2026
Five-Year Real-World Hard Outcomes of Vedolizumab in Inflammatory Bowel Disease: The IG-IBD LONG-LIVE StudyGiuseppe Privitera, Flavia Palumbo, Fabio Salvatore Macaluso, et al.
Journal of Clinical Medicine|July 2, 2021
Effectiveness of Third-Class Biologic Treatment in Crohn's Disease: A Multi-Center Retrospective Cohort StudyAhmad Albshesh, Joshua Taylor, Edoardo V Savarino, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 13, 2025
Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning-the IG-IBD LIVE studyDaniela Pugliese, Giuseppe Privitera, Nicola Cersullo, et al.
United European Gastroenterology Journal|November 8, 2024
Sex-related differences in the presentation, management and response to treatment of eosinophilic esophagitis: Cross sectional analysis of EoE CONNECT registryEmilio J Laserna-Mendieta, Sergio Casabona-Francés, Edurne Amorena, et al.
Pageof 3